phentermine a glp-1 may help certain patients lose more weight after discontinuing GLP-1s Phentermine in Kansas City |

Defined as less than 10% total body weight loss by month 6, or weight-loss plateau with more than 10% remaining to goal

Leonard Davis Institute of Health Economics

There has been a marked increase in the use of these medications since they were first approved for weight loss in 2014, particularly following the approval of Wegovy in 2021 and Zepbound in 2022

Dual GLP-1/GIP agonists are in preclinical evaluation for synergistic neuroprotection

Translational Perspectives and Future Directions The growing body of evidence reviewed throughout this article positions GLP-1RAs as promising pharmacological tools for the treatment of SUDs

Ozempic is a widely prescribed medication for managing type 2 diabetes and is also well known for its weight loss effects, even though its not FDA-approved for weight management